Diseases are evolving faster than traditional methods can keep up, making it harder to develop effective therapies. These traditional methods are simply too slow and can’t keep up with rapidly mutating pathogens. Mabloc’s BRAID™ platform changes this by using AI to uncover rare, powerful antibodies—super antibodies—that can target a wide range of diseases and genetic variations. By harvesting tens of thousands of antibody sequences and pinpointing those with the greatest potential—this approach eliminates traditional development bottlenecks. And it allows us to fast-track breakthrough therapies into the clinic, unlock treatments that were once considered out of reach, and expand the possibilities for others. With BRAID™, we’re not just responding to current health threats—we’re shaping a future where adaptable therapies redefine what's possible in medicine.
BRAID™ is a groundbreaking platform that reshapes how we discover and develop antibodies. It moves quickly from design to selection, reducing hundreds of thousands of sequences to those few that are most optimized to the target disease. It can even do this as the pathogens evolve and in doing so it increases the clinical longevity of the therapeutic. This approach significantly shortens the traditional timeline, taking us from discovery to fully validated antibodies in record time. BRAID™ represents a breakthrough in the fight against rapidly changing diseases, opening up new possibilities in therapeutic development.
Mabloc’s BRAID™ platform transforms antibody development by streamlining every phase—from discovery to clinical trials. We harvest hundreds of thousands of antibody sequences and, with AI precision, sift through them to pinpoint the candidates with the highest therapeutic potential. Our approach isn’t just faster—it’s smarter. By streamlining each stage of development, we help drug makers accelerate timelines, reduce costs, and increase the likelihood of success. With faster, more efficient discovery, we empower our partners to bring breakthrough therapies to patients even sooner.
"At Mabloc, we’re focused on one thing: making sure our therapies reach people as soon as possible. With BRAID™, we’re not waiting around for years—we’re pushing to get life-saving treatments into the hands of those who need them, now. I always tell my team, ‘We’re doing this today, not in some distant future.’ That’s what drives us every day.”
